HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

3- morpholinomethyl- 3',4',5,7- tetramethoxyflavone

structure in first source

Also Known As:

FB277

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyrans: 130
    - Benzopyrans: 195
      - Chromones: 159
        Flavonoids: 9773
        3-morpholinomethyl-3',4',5,7-tetramethoxyflavone: 1
  - Oxazines: 9
    - Morpholines: 6
      - 3-morpholinomethyl-3',4',5,7-tetramethoxyflavone: 1
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Benzopyrans: 195
      - Chromones: 159
        Flavonoids: 9773
        3-morpholinomethyl-3',4',5,7-tetramethoxyflavone: 1

Related Diseases

1.

01/15/1999 - "In contrast, FB277 (3.75 mg/kg i.v.) did not increase the signal in the cortex during ischemia-reperfusion, but did do so in the cerebellum (to 152% of control, P < 0.05). "
01/15/1999 - "We characterized the changes in nitric oxide (NO) levels in the brain during global forebrain ischemia and reperfusion and tested the ability of the natural flavonoid, quercetin, and a synthetic flavonoid, FB277, to increase the amount of available NO by elimination of the superoxide radicals produced during reperfusion. "

Related Drugs and Biologics

1.	Superoxides (Superoxide)
2.	Quercetin
3.	Nitric Oxide (Nitrogen Monoxide)
4.	Flavonoids